*

Market Insights

Stock screens updated daily — built in Wright’s visual language.

Stock screens updated daily — built in Wright’s visual language.

Top Growth Stocks

"Growth" stocks are equities of companies expected to grow at a faster rate than the average market. These stocks typically have high earnings and revenue growth potential. Key characteristics include a focus on reinvesting profits into expanding the business rather than paying dividends, leading to potential capital gains for investors. Advantages of investing in growth stocks include the potential for significant returns over time if the company achieves its growth targets.

Updated:
Ticker Security Name ⇅ PrevClose Beta MarketCap PE Ratio ⇅ Dividend Yield PBV Ratio ⇅ Category
ANANTRAJ Anant Raj Ltd. 551.1 1.016 16771.467 41.322 0.002 4.211 Mid-Cap
CGCL Capri Global Capital Ltd. 183.96 0.306 13125.966 33.256 0.001 3.143 Mid-Cap
ASTRAZEN Astrazeneca Pharma India Ltd. 8340.0 0.434 19188.844 191.205 0.003 27.144 Mid-Cap
CHOICEIN Choice International Ltd. 820.2 0.376 9596.442 62.893 0.0 10.351 Mid-Cap
CCL CCL Products (India) Ltd. 942.4 0.609 7616.44 26.774 0.008 4.033 Mid-Cap
ASTRAMICRO Astra Microwave Products Ltd. 986.7 1.073 5916.031 42.517 0.003 5.797 Mid-Cap
CENTURYPLY Century Plyboards (India) Ltd. 770.5 0.969 15684.282 71.174 0.001 6.679 Mid-Cap
AURIONPRO Aurionpro Solutions Ltd. 1055.4 0.775 7208.391 38.373 0.001 4.928 Mid-Cap
ALKYLAMINE Alkyl Amines Chemicals Ltd. 1557.6 0.933 8315.731 44.924 0.006 6.091 Mid-Cap
CAPLIPOINT Caplin Point Laboratories Ltd. 1813.5 0.752 14000.958 26.302 0.003 5.291 Mid-Cap
No data found for this filter.

Select a filter to view information.

Details

About Anant Raj Ltd. and Its Industry:

Anant Raj Ltd. is a real estate development company based in India, focusing primarily on commercial and residential properties. With a strong presence in key markets, the company has established itself as a reputable player in the real estate industry. Anant Raj Ltd. is known for its innovative designs, quality construction, and customer-centric approach, which have contributed to its success over the years. Despite its solid reputation, Anant Raj Ltd. faces challenges such as regulatory changes impacting the real estate sector and evolving market demand for sustainable and tech-enabled properties. However, these challenges also present opportunities for the company to adapt, innovate, and differentiate itself by embracing new technologies, sustainability practices, and customer preferences. By navigating these challenges effectively, Anant Raj Ltd.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹551.1
    • Market Cap: ₹16771.467
    • Category: Mid-Cap
    • Beta: 1.016
  • P/E Ratio: 41.322
  • Dividend Yield: 0.002%
  • Price-to-Book Value (PBV): 4.211

About Capri Global Capital Ltd. and Its Industry:

Capri Global Capital Ltd. is a diversified non-banking financial company (NBFC) operating in India. With a focus on providing financial solutions to individuals and small businesses, Capri Global Capital offers a range of services including home loans, loans against property, business loans, and microfinance. The company has established itself as a reliable financial partner for those seeking credit in the Indian market. Known for its customer-centric approach, Capri Global Capital aims to empower individuals and businesses by offering flexible and tailored financial solutions. Despite its strong market presence, Capri Global Capital faces challenges in a competitive and rapidly evolving financial services industry. Regulatory changes and compliance requirements can impact the company's operations and profitability.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹183.96
    • Market Cap: ₹13125.966
    • Category: Mid-Cap
    • Beta: 0.306
  • P/E Ratio: 33.256
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 3.143

About Astrazeneca Pharma India Ltd. and Its Industry:

AstraZeneca Pharma India Ltd. is a subsidiary of the global pharmaceutical giant AstraZeneca. The company operates in the pharmaceutical industry, focusing on research, development, manufacturing, and marketing of a wide range of pharmaceutical products. AstraZeneca Pharma India plays a significant role in the Indian healthcare sector by providing innovative and high-quality medicines to address various medical needs, ranging from cardiovascular diseases to respiratory conditions. In a rapidly evolving pharmaceutical landscape, AstraZeneca Pharma India faces challenges such as increasing competition, pricing pressures, and regulatory hurdles that impact its market positioning and profitability. However, the company also has opportunities to capitalize on growing healthcare needs, advancements in technology, and the increasing focus on research and development to introduce new products.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹8340.0
    • Market Cap: ₹19188.844
    • Category: Mid-Cap
    • Beta: 0.434
  • P/E Ratio: 191.205
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 27.144

About Choice International Ltd. and Its Industry:

Choice International Ltd. is a multinational company operating in the financial services sector, offering a wide range of investment and wealth management services to a diverse client base. With a strong focus on personalized financial solutions, the company has built a reputation for delivering innovative strategies tailored to meet the unique needs of individual and institutional investors. Its comprehensive suite of offerings includes asset management, financial planning, retirement services, and advisory services. In the competitive landscape of the financial services industry, Choice International Ltd. faces challenges such as increasing regulatory scrutiny, evolving customer preferences, and technological disruptions. Navigating these complexities while maintaining a high level of service and compliance with industry standards remains a key challenge for the company.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹820.2
    • Market Cap: ₹9596.442
    • Category: Mid-Cap
    • Beta: 0.376
  • P/E Ratio: 62.893
  • Dividend Yield: 0.0%
  • Price-to-Book Value (PBV): 10.351

About CCL Products (India) Ltd. and Its Industry:

CCL Products (India) Ltd. is a leading player in the global coffee industry, specializing in the manufacturing and marketing of instant coffee. The company prides itself on its state-of-the-art production facilities and an extensive distribution network that spans across various continents. CCL Products has established itself as a trusted supplier, offering a diverse range of high-quality coffee products to meet the varying demands of its customers worldwide. In an increasingly competitive market, CCL Products faces challenges such as fluctuating coffee prices, currency exchange rates, and evolving consumer preferences. However, the company also has significant opportunities for growth, including expanding its presence in emerging markets, diversifying its product offerings, and leveraging technological advancements for operational efficiency.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹942.4
    • Market Cap: ₹7616.44
    • Category: Mid-Cap
    • Beta: 0.609
  • P/E Ratio: 26.774
  • Dividend Yield: 0.008%
  • Price-to-Book Value (PBV): 4.033

About Astra Microwave Products Ltd. and Its Industry:

Astra Microwave Products Ltd. is a leading Indian company specializing in the design, development, and production of high-performance electronic systems and products for the defense, space, and telecom industries. With a focus on cutting-edge technology and innovation, Astra Microwave has established itself as a reliable partner for critical communication and defense systems, providing solutions that cater to the evolving needs of its clients in both domestic and international markets. Challenges facing Astra Microwave Products Ltd. include intensifying competition in the electronics industry, technological disruptions, and the need to constantly innovate to maintain a competitive edge. Additionally, regulatory changes in the defense and telecom sectors pose challenges in terms of compliance and adaptation.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹986.7
    • Market Cap: ₹5916.031
    • Category: Mid-Cap
    • Beta: 1.073
  • P/E Ratio: 42.517
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.797

About Century Plyboards (India) Ltd. and Its Industry:

Century Plyboards (India) Ltd. is a prominent player in the wood products industry, specializing in manufacturing a wide range of plywood, laminates, veneers, and other engineered wood products. With a strong presence in the Indian market, the company caters to various segments including residential, commercial, and industrial construction projects. Their products are known for their quality, durability, and innovation, making Century Plyboards a trusted brand among consumers, architects, and interior designers. Despite its established position in the industry, Century Plyboards faces challenges such as intense competition from both domestic and international players, fluctuating raw material prices, and changing consumer preferences towards alternative building materials.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹770.5
    • Market Cap: ₹15684.282
    • Category: Mid-Cap
    • Beta: 0.969
  • P/E Ratio: 71.174
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 6.679

About Aurionpro Solutions Ltd. and Its Industry:

Aurionpro Solutions Ltd. is a global technology solutions provider that caters to various industries, including banking, financial services, and insurance. The company offers innovative digital solutions, cybersecurity services, and consulting expertise to help organizations optimize their operations and enhance customer experiences. With a focus on cutting-edge technologies such as artificial intelligence and blockchain, Aurionpro Solutions aims to drive digital transformation for its clients and stay at the forefront of the rapidly evolving tech landscape. Despite its strong market position and innovative solutions, Aurionpro Solutions faces challenges in terms of intensifying competition from both traditional players and new market entrants. Staying ahead of the technological curve and maintaining relevance in a fast-paced industry pose ongoing challenges for the company.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1055.4
    • Market Cap: ₹7208.391
    • Category: Mid-Cap
    • Beta: 0.775
  • P/E Ratio: 38.373
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 4.928

About Alkyl Amines Chemicals Ltd. and Its Industry:

Alkyl Amines Chemicals Ltd. is a prominent player in the chemical industry, specializing in the production of a wide range of amines and amine derivatives. With a focus on quality and innovation, the company has established a strong presence both domestically and internationally. Its operations encompass manufacturing, research and development, and distribution, catering to diverse sectors such as pharmaceuticals, agrochemicals, and surfactants. One of the key challenges facing Alkyl Amines Chemicals Ltd. is navigating the highly competitive nature of the chemical industry, where rapid technological advancements and changing consumer preferences require continuous adaptation and investment in research and development.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1557.6
    • Market Cap: ₹8315.731
    • Category: Mid-Cap
    • Beta: 0.933
  • P/E Ratio: 44.924
  • Dividend Yield: 0.006%
  • Price-to-Book Value (PBV): 6.091

About Caplin Point Laboratories Ltd. and Its Industry:

Caplin Point Laboratories Ltd. is a pharmaceutical company that focuses on developing, manufacturing, and marketing generic pharmaceutical formulations in several therapeutic areas. With a strong presence in emerging markets, Caplin Point has established itself as a key player in the pharmaceutical industry by providing affordable and high-quality medicines to a wide range of customers. The company's operations are characterized by its commitment to innovation, quality control, and regulatory compliance, ensuring that its products meet international standards. Challenges for Caplin Point Laboratories Ltd. include navigating the complex landscape of changing regulations and increasing competition within the pharmaceutical industry. Additionally, the company may face challenges related to maintaining a sustainable supply chain in a global market environment.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1813.5
    • Market Cap: ₹14000.958
    • Category: Mid-Cap
    • Beta: 0.752
  • P/E Ratio: 26.302
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.291